2025
SJR Q2
JCR Q1 · 2,8
126 eşleşen makale
SCIE
Dergi ayrıntısı
Current Medical Research and Opinion
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0300799514734877
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,83
- Quartile Q2
- H-Index 129
- Atıf/yayın 2,75
- Doküman (3y) 699
- Atıf (3y) 1.799
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 2,8
- 5Y JIF 2,6
- JCI 0,53
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Medicine (miscellaneous) Q2
Alanlar
- Medicine
WoS kategorileri
- Medicine, General & Internal | Medicine, Research & Experimental
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q1 | 0,83 | 2,8 | 2,6 | 0,53 | Q2 | 129 |
| 2024 | Q2 | Q2 | 0,786 | 2,2 | 2,3 | 0,52 | Q2 | 125 |
| 2023 | Q2 | Q1 | 0,712 | 2,4 | 2,5 | 0,51 | Q2 | 125 |
| 2022 | Q2 | Q3 | 0,643 | 2,3 | 2,2 | 0,5 | Q2 | 125 |
| 2021 | Q2 | Q3 | 0,689 | 2,7 | 2,5 | 0,53 | Q2 | 125 |
| 2020 | Q2 | Q2 | 0,708 | 2,6 | 2,5 | 0,72 | Q1 | 125 |
| 2019 | Q2 | Q2 | 0,712 | 2,3 | 2,2 | 0,76 | Q1 | 125 |
| 2018 | — | Q2 | — | 2,3 | 2,5 | 0,83 | Q1 | — |
| 2017 | Q1 | Q1 | 0,944 | 2,7 | 2,7 | 0,91 | Q1 | 125 |
| 2016 | Q1 | Q1 | 0,991 | 2,8 | 2,6 | — | — | 125 |
| 2015 | Q1 | Q1 | 1,004 | 2,6 | 2,4 | — | — | 125 |
| 2014 | Q1 | Q1 | 1,002 | 2,7 | 2,4 | — | — | 125 |
| 2013 | Q1 | Q1 | 0,965 | 2,4 | 2,4 | — | — | 125 |
| 2012 | Q1 | Q1 | 0,953 | 2,3 | 2,4 | — | — | 125 |
| 2011 | Q1 | Q1 | 0,998 | 2,4 | 2,5 | — | — | 125 |
| 2010 | Q1 | Q1 | 1,031 | 2,6 | 2,6 | — | — | 125 |
| 2009 | — | Q1 | — | 2,5 | 2,7 | — | — | — |
| 2008 | — | Q2 | — | 2,6 | 2,9 | — | — | — |
| 2007 | — | Q1 | — | 3 | 3 | — | — | — |
| 2006 | — | Q1 | — | 3,1 | — | — | — | — |
| 2005 | — | Q1 | — | 2,9 | — | — | — | — |
| 2004 | — | Q1 | — | 2,9 | — | — | — | — |
| 2003 | — | Q1 | — | 2,7 | — | — | — | — |
| 2002 | — | Q1 | — | 1,9 | — | — | — | — |
| 2001 | — | Q1 | — | 1,6 | — | — | — | — |
| 2000 | — | Q2 | — | 1 | — | — | — | — |
| 1999 | — | Q2 | — | 0,7 | — | — | — | — |
| 1998 | — | Q2 | — | 0,7 | — | — | — | — |
| 1997 | — | Q3 | — | 0,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | Q2 | 80/336 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 103/191 |
| 2024 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 90/332 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 109/195 |
| 2023 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | Q2 | 81/329 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 106/189 |
| 2022 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 100/169 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 103/136 |
| 2021 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 94/172 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 107/139 |
| 2020 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q1 | 70/167 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 102/140 |
| 2019 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q1 | 61/165 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 93/139 |
| 2018 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q1 | 51/160 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 77/136 |
| 2017 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | Q1 | 36/155 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 68/133 |
| 2016 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 33/155 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 53/128 |
| 2015 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 30/155 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 54/124 |
| 2014 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 32/154 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 55/123 |
| 2013 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 35/156 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 59/124 |
| 2012 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 36/155 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 61/121 |
| 2011 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 32/155 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 53/112 |
| 2010 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 29/153 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 40/106 |
| 2009 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 26/133 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 38/93 |
| 2008 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 27/107 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 32/83 |
| 2007 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 18/100 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 23/81 |
| 2006 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 17/103 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 20/76 |
| 2005 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 18/105 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 17/72 |
| 2004 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 15/103 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 18/71 |
| 2003 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 16/102 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 17/72 |
| 2002 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 23/107 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 29/74 |
| 2001 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | — | 27/112 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 33/75 |
| 2000 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 36/105 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 44/74 |
| 1999 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 41/110 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 50/76 |
| 1998 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 42/107 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 40/72 |
| 1997 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 58/100 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 47/61 |